Kelly Mercier, , shared a post on X:
“Fantastic description of the personalized lung cancer approaches – and how it is frustrating when it doesn’t go well.
Eric K. Singhi approaches decisions with histology, molecular data, and patient factors.”
More posts featuring Kelly Mercier on OncoDaily.
